GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunny Pharmtech Inc (ROCO:6676) » Definitions » Land And Improvements

Sunny Pharmtech (ROCO:6676) Land And Improvements : NT$0.0 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sunny Pharmtech Land And Improvements?

Sunny Pharmtech's land and improvements for the quarter that ended in Dec. 2024 was NT$0.0 Mil.


Sunny Pharmtech Land And Improvements Historical Data

The historical data trend for Sunny Pharmtech's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunny Pharmtech Land And Improvements Chart

Sunny Pharmtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Land And Improvements
Get a 7-Day Free Trial - - - - -

Sunny Pharmtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sunny Pharmtech Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Sunny Pharmtech Business Description

Traded in Other Exchanges
N/A
Address
No.255,Longyuan 1st Road, Hsinchu Science Park, Longtan District, Taoyuan, TWN, 325002
Sunny Pharmtech Inc is a specialty pharmaceutical company. It is now fully-integrated, doing research, development, and manufacturing on both API and finished-dose products, which includes orals, liquids, semi-solids, and parenterals.

Sunny Pharmtech Headlines

No Headlines